NOV Inc
NOV
18.62
-0.38
-2.00%
NOV Inc
US · NOV
#1825 by market cap
Listed 1970
18.62
-0.38
-2.00%
Live - 5344 symbols - heartbeat 450s ago
· 2026-10-08 04:01
Pre-market
18.62
0.00%
After-hours
18.62
0.00%
Overnight
18.44
-0.97%
- Market cap
- 6.64B
- P/E (TTM)i
- 68.96
- P/Bi
- 1.07
- EPSi
- 0.39
- Div yieldi
- 2.26%
- 52W posi
- 67%
Reader sentiment
Are you bullish or bearish on NOV?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.02, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -1.42% YoY
Margins
- Gross margin
- 20.21%
- Operating margin
- 6.45%
- Net margin
- 1.66%
Key ratios & quality
- Enterprise valuei
- 6.90B
- Altman Z-Scorei
- 2.02
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.45B | 8.48B | 6.09B | 5.52B | 7.24B | 8.58B | 8.87B | 8.74B |
| Gross profit | 1.44B | 845.00M | 434.00M | 774.00M | 1.33B | 1.83B | 2.01B | 1.77B |
| Selling & admin expenses | 1.23B | 1.30B | 968.00M | 908.00M | 1.07B | 1.18B | 1.13B | 1.20B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 211.00M | -458.00M | -534.00M | -134.00M | 264.00M | 651.00M | 876.00M | 564.00M |
| Pretax profit | 41.00M | -6.46B | -2.78B | -230.00M | 238.00M | 612.00M | 831.00M | 375.00M |
| Tax | 63.00M | -369.00M | -242.00M | 15.00M | 83.00M | -373.00M | 196.00M | 224.00M |
| Net profit | -22.00M | -6.09B | -2.54B | -245.00M | 155.00M | 985.00M | 635.00M | 151.00M |
| Basic EPS | 0 | -16 | -7 | -1 | 0 | 3 | 2 | 0 |
| Diluted EPS | -0.08 | -15.96 | -6.62 | -0.65 | 0.39 | 2.50 | 1.60 | 0.39 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 2.10B | 2.19B | 2.18B | 2.28B | 2.05B | 2.13B |
| Gross profit | 447.00M | 446.00M | 412.00M | 462.00M | 379.00M | 521.00M |
| Selling & admin expenses | 295.00M | 303.00M | 305.00M | 300.00M | 332.00M | 328.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 152.00M | 143.00M | 107.00M | 162.00M | 47.00M | 193.00M |
| Pretax profit | 121.00M | 115.00M | 73.00M | 66.00M | 35.00M | 157.00M |
| Tax | 47.00M | 1.00M | 29.00M | 147.00M | 15.00M | 41.00M |
| Net profit | 74.00M | 114.00M | 44.00M | -81.00M | 20.00M | 116.00M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.19 | 0.29 | 0.11 | -0.21 | 0.05 | 0.31 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 7.28B | 6.11B | 5.21B | 4.90B | 5.49B | 5.84B | 5.77B | 5.82B |
| Cash & ST investments | 1.43B | 1.17B | 1.69B | 1.59B | 1.07B | 816.00M | 1.23B | 1.55B |
| Inventory | 2.99B | 2.20B | 1.41B | 1.33B | 1.81B | 2.15B | 1.93B | 1.80B |
| Total assets | 19.80B | 13.15B | 9.93B | 9.55B | 10.14B | 11.29B | 11.36B | 11.29B |
| Total current liabilities | 2.34B | 2.25B | 1.87B | 1.91B | 2.44B | 2.44B | 2.35B | 2.41B |
| Short-term debt | 7.00M | 114.00M | 110.00M | 104.00M | 100.00M | 107.00M | 139.00M | 131.00M |
| Long-term debt | 2.48B | 1.99B | 1.83B | 1.71B | 1.72B | 1.71B | 1.70B | 1.69B |
| Total liabilities | 5,907,000,000.00 | 5,303,000,000.00 | 4,650,000,000.00 | 4,486,000,000.00 | 5,001,000,000.00 | 5,052,000,000.00 | 4,933,000,000.00 | 4,969,000,000.00 |
| Total equity | 13.89B | 7.85B | 5.28B | 5.06B | 5.13B | 6.24B | 6.43B | 6.32B |
| Retained earnings | 6.86B | 690.00M | -1.88B | -2.15B | -2.07B | -1.16B | -628.00M | -673.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 5.78B | 5.78B | 5.76B | 5.82B | 5.72B | 5.79B |
| Cash & ST investments | 1.16B | 1.08B | 1.21B | 1.55B | 1.34B | 1.16B |
| Inventory | 1.94B | 1.93B | 1.89B | 1.80B | 1.87B | 1.95B |
| Total assets | 11.27B | 11.36B | 11.34B | 11.29B | 11.14B | 11.20B |
| Total current liabilities | 2.18B | 2.24B | 2.26B | 2.41B | 2.32B | 2.39B |
| Short-term debt | 140.00M | 141.00M | 135.00M | 131.00M | 127.00M | 114.00M |
| Long-term debt | 1.70B | 1.69B | 1.69B | 1.69B | 1.69B | 1.69B |
| Total liabilities | 4,779,000,000.00 | 4,805,000,000.00 | 4,826,000,000.00 | 4,969,000,000.00 | 4,875,000,000.00 | 4,938,000,000.00 |
| Total equity | 6.49B | 6.56B | 6.51B | 6.32B | 6.27B | 6.26B |
| Retained earnings | -583.00M | -582.00M | -568.00M | -673.00M | -687.00M | -639.00M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 521.00M | 714.00M | 926.00M | 291.00M | -179.00M | 143.00M | 1.30B | 1.25B |
| Depreciation & amortization | 690.00M | 533.00M | 352.00M | 306.00M | 301.00M | 302.00M | 343.00M | 355.00M |
| Free cash flow | 277.00M | 481.00M | 700.00M | 90.00M | -393.00M | -140.00M | 953.00M | 876.00M |
| Dividends paid | -76.00M | -77.00M | -19.00M | -20.00M | -78.00M | -79.00M | -108.00M | -190.00M |
| Stock buybacks / issuance | -- | -- | -- | -- | 0 | 0 | -229.00M | -315.00M |
| Ending cash balance | 1.43B | 1.17B | 1.69B | 1.59B | 1.07B | 816.00M | 1.23B | 1.55B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 135.00M | 191.00M | 352.00M | 573.00M | -26.00M | 17.00M |
| Depreciation & amortization | 89.00M | 87.00M | 89.00M | 90.00M | 92.00M | 93.00M |
| Free cash flow | 51.00M | 108.00M | 245.00M | 472.00M | -91.00M | -64.00M |
| Dividends paid | -28.00M | -107.00M | -28.00M | -27.00M | -33.00M | -64.00M |
| Stock buybacks / issuance | -81.00M | -69.00M | -80.00M | -85.00M | -67.00M | -63.00M |
| Ending cash balance | 1.16B | 1.08B | 1.21B | 1.55B | 1.34B | 1.16B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -0.22 | -56.44 | -39.14 | -4.90 | 3.07 | 17.63 | 10.12 | 2.29 |
| ROA %i | -0.16 | -37.00 | -22.03 | -2.57 | 1.57 | 9.27 | 5.61 | 1.28 |
| ROIC %i | 0.11 | -44.45 | -26.98 | -2.64 | 2.61 | 12.96 | 7.81 | 1.99 |
| 5-year avg ROE %i | -2.06 | -15.68 | -22.68 | -20.48 | -19.53 | -15.96 | -2.64 | 5.64 |
| EBIT margin %i | 1.59 | -75.03 | -44.25 | -2.77 | 4.37 | 8.16 | 10.39 | 5.30 |
| FCF / sales %i | 3.28 | 5.67 | 11.49 | 1.63 | -- | -- | 10.74 | 10.02 |
| Current ratioi | 3.11 | 2.72 | 2.79 | 2.57 | 2.25 | 2.40 | 2.46 | 2.42 |
| Quick ratioi | 1.75 | 1.63 | 1.92 | 1.77 | 1.43 | 1.42 | 1.54 | 1.60 |
| Debt / assetsi | 13.69 | 21.12 | 25.74 | 25.01 | 23.34 | 21.05 | 21.00 | 20.72 |
| LT debt / equityi | 19.57 | 34.24 | 46.95 | 45.71 | 44.47 | 36.80 | 35.24 | 35.24 |
| Interest coveragei | 1.44 | -63.62 | -32.08 | -1.99 | 4.05 | 7.95 | 10.13 | 5.26 |
| Revenue CAGR (3Y) %i | -16.95 | 5.35 | -5.88 | -13.22 | -5.14 | 12.12 | 17.10 | 6.51 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -2.20 |
| FCF CAGR (3Y) %i | -31.95 | -10.72 | 3.03 | -31.25 | -- | -- | 119.59 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 9.29 | 7.31 | 5.93 | 2.29 | 1.44 | 1.50 |
| ROA %i | 5.22 | 4.16 | 3.37 | 1.28 | 0.81 | 0.84 |
| ROIC %i | 7.13 | 5.75 | 4.75 | 1.99 | 1.30 | 1.35 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 9.93 | 7.94 | 6.81 | 5.30 | 4.34 | 4.84 |
| FCF / sales %i | 13.05 | 10.34 | 9.99 | 10.02 | 8.44 | 6.51 |
| Current ratioi | 2.65 | 2.58 | 2.55 | 2.42 | 2.47 | 2.42 |
| Quick ratioi | 1.66 | 1.62 | 1.61 | 1.60 | 1.57 | 1.52 |
| Debt / assetsi | 21.05 | 20.87 | 20.77 | 20.72 | 20.99 | 20.77 |
| LT debt / equityi | 34.67 | 34.29 | 34.39 | 35.24 | 35.61 | 35.65 |
| Interest coveragei | 9.84 | 7.84 | 6.64 | 5.26 | 4.28 | 4.80 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Energy Equipment is the largest reported line at 57.08% of revenue, across 3 reported segments.
- Energy Products and Services follows at 45.64%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Energy Equipment57.08%
Energy Products and Services45.64%
Quote time 2026-10-08 04:01:02 · For reference only, not investment advice and not tailored to your situation.